5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Clinical trial NCT00433927 · UNKNOWN

Trial details

NCT number: NCT00433927
Sponsor: PD Dr. med. Volker Heinemann
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasm Metastasis Colorectal Cancer

Start date: 2007-01-01
Primary completion: 2014-04-01
Enrollment: 568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.